Monday, May 23, 2022

ICMR study states that Covaxin is effective against multiple variants of SARS Covid-19.

Bharat Biotech’s Covid-19 vaccine is a locally produced product. SARS-CoV-2 variants can be neutralized by covaxin. According to the Indian Council of Medical Research (ICMR), covaxin is also involved in neutralizing the double mutant strain.

“ICMR analysis shows #COVAXIN neutralizes many strains of SARS-CoV-2 and effectively neutralizes the double mutant strain as well,” the ICMR said in a tweet.

Multiple SARS-CoV-2 virus variants of concern have been successfully isolated and cultured by the ICMR-National Institute of Virology: B.1.1.7 (UK variant), B.1.1.28 (Brazil variant), and B.1.351 (US variant) (South Africa variant)

Covaxin’s neutralization ability against the UK and Brazil variants has been demonstrated by the ICMR-NIV, according to the apex health research body.

The ICMR-NIV recently succeeded in isolating and culturing the double mutant strain B.1.617 SARS-CoV-2 found in India and several other countries, according to the ICMR.

ALSO CHECK: Get a tremendous discount with Firsrtcry Coupon Code and Mamaearth Coupons

It added, “Covaxin has also been found to effectively neutralize the double mutant strain.”

In the meantime, the Serum Institute of India (SII) has set the price of the Covishield vaccine at 600 rupees per shot for private hospitals and 400 rupees per jab for state governments, according to a press release.

Both people over the age of 18 have been able to get vaccinated since May 1. In the first step of India’s vaccination campaign, priority was given to both healthcare and frontline staff. The second step began on March 1, with doses being given to people over the age of 60 and those between the ages of 45 and 59 who had unique comorbidities.

For its COVID-19 inoculation program, India now has three vaccines: Covishield, Covaxin, and Sputnik V.

Meanwhile, Bharat Biotech’s chairman and managing director Krishna Ella said on Tuesday that the company will manufacture 30 million doses of its Covid-19 vaccine, Covaxin, next month, up from 15 million doses in March, to help the country’s vaccination campaign. In a tweet, the vaccine maker said that it has increased its Covaxin production ability to 700 million doses per year. The remarks come as Prime Minister Narendra Modi has urged vaccine manufacturers to increase manufacturing capacity so that all Indians can be inoculated as soon as possible. The government has also authorized payment of around Rs. 4,500 crore as an advance to vaccine manufacturers such as Serum Institute of India (SII) and Bharat Biotech for future supplies.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Latest

COVID-19: First case of Omicron sub-variant BA.4 reported in Tamil Nadu

COVID-19: Those who came in contact with the woman were not affected. The health secretary and senior officials of the department had met her...

Covid-19 fourth wave: India has recorded 2,202 new infections and 27 deaths in the last 24 hours.

The death toll has risen to 5,24,241 with 27 more fatalities, according to figures updated at 8 a.m. According to the ministry, active cases...

Corona 4th Wave: Corona’s fourth wave has arrived in the country! This was stated by an expert from the ICMR.

Covid 4th Wave: Corona instances are on the rise in the United States these days. In the meantime, ICMR expert Samiran Panda has provided...

Update on COVID-19: Delhi sees the highest number of cases and 30 deaths in the last 24 hours

Following the record high of 28,867 cases on January 13, there have been fewer cases occurring every day since then. A positivity rate of...

Precaution! Fraud in the name of a booster dose of COVID, the full money will be deducted from the account as soon as OTP...

Citizens above 60 years of age have started getting booster doses in India and fraudsters are taking advantage of it. Fraudsters have found a...

Most Popular

Subscribe

* indicates required